AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymche...
The globally active life science company Eppendorf SE is taking the next major step in expanding its international manuf...
Nippon Kayaku and Celltrion Healthcare Japan K.K. have entered into a Memorandum of Understanding (MoU) on Compreh...
Harbour BioMed, a US-based biopharmaceutical company, has entered into a strategic collaboration with China Nationa...
US-based Waters Corporation has announced the launch of the Xevo TQ Absolute XR IVD Mass Spectrometer, expanding it...
HoneyNaps has officially registered as a Contract Research Organization (CRO) with the Korea National Enterprise for Cli...
Hong Kong-based Home Control International has announced that its wholly-owned subsidiary, Orbiva has entered into ...
Japan-based Shimadzu Corporation has announced the release of the GCMS-TQ8040 RX and GCMS-TQ8050 RX gas chromatogra...
Takeda China has announced that the National Medical Products Administration (NMPA) has approved the use of ORZEYFUL (ov...
It is estimated that by 2040 China-originated treatments will represent 35% of US FDA approvals. When marketing treatmen...
GCCL, a South Korea-based leading provider of clinical trial sample analysis, and China & US based GemPharmatech, a ...
Gerresheimer, an innovative system and solution provider and global partner to the pharma, biotech, and cosmetic industr...
US-based BostonGene, the developer of the leading AI model for tumour and immune biology, has announced a strategic...
M42’s National Reference Laboratory (NRL), a leading provider of diagnostic services in the region, has entered in...
Africa carries the majority of the global sickle cell disease burden, yet care across many health systems remains fragme...
Tikva Allocell, a Singapore-based biotechnology startup developing engineered, allogeneic (donor-derived) cell therapies...
The next generation of cell and gene therapies is pushing manufacturing beyond the limits of conventiona...
Exosomes are rapidly emerging as one of the most promising frontiers in regenerative medicine, offering the therapeutic ...
JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies for rare and gen...
South Korea-based Seegene, Inc., a global leader in molecular diagnostics, has announced that its US subsidiary, Seegene...
As BIO Asia–Taiwan 2026 brought the region’s biotechnology and healthcare ecosystem together in Taip...
Fangzhou Inc. has announced the launch of Kyinsu®, the world's first once-weekly basal insulin/GLP-1 RA combination ...
South Korea-based Samsung Biologics has announced the launch of an all-cash public tender offer to acquire 100% of the f...
Galderma has announced the launch of Alastin – its premium regenerative skincare brand – across the JPAC reg...
Merck, a leading science and technology company, has opened a new €25 million BioReliance® testing facility at ...
